DUBLIN--(BUSINESS WIRE)--Research and Markets (http://www.researchandmarkets.com/research/g5fv3k/special_report) has announced the addition of Decision Resources, Inc's new report "Special Report: Evolving Patterns and Unmet Needs in the TB Population in Developing and Developed Markets" to their offering.
The combination of animal-human transmission, opportunistic infection in AIDS patients, and rapid urbanization has led to sharp increases in tuberculosis (TB) cases in many parts of the world. Although the number of TB cases will decline over the coming decade as public health improves and the use of HAART (highly active antiretroviral therapy) becomes more widespread, TB will continue to be a public health concern and multidrug resistance a continuing problem in its treatment.
Topics Covered:
Executive Summary Strategic Considerations Introduction Epidemiology Diagnosed Incident Cases Brazil China India Russia South Africa Developed Countries HIV-Associated Cases Extrapulmonary TB Cases Medical Practice Drug Resistance Drug Toxicity Appendix A: Bibliography
Tables
1. Number of Diagnosed Active TB Cases per Year in a Selection of Developed and Developing Countries, 2010-2020 2. Number of Diagnosed HIV-Associated Active TB Cases per Year in a Selection of Developed and Developing Countries, 2010-2020 3. Number of Diagnosed Extrapulmonary Active TB Cases per Year in a Selection of Developed and Developing Countries, 2010-2020 4. Recently Published Guidelines and Recommendations for Drug Treatment of TB 5. Patient Share of Commonly Recommended First-Line Drug Regimens 6. Number of Diagnosed Active Multidrug-Resistant TB cases per Year in a Selection of Developed and Developing Countries, 2010-2020 7. Number of Diagnosed Active Extensively Drug-Resistant TB Cases per Year in a Selection of Developing Countries, 2010-2020
Figures
1. TB Incidence in Selected Developed and Developing Countries, 2010-2020
For more information visit http://www.researchandmarkets.com/research/g5fv3k/special_report
Source: Decision Resources, Inc